Security key
00808Y406
Aethlon Medical, Inc. - Common Stock, $0.001 par value per share (AEMD)
CUSIP: 00808Y406
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Total 13F shares
- 3,383,404
- Total 13F value
- $1,210,381
- Share change
- +1,776,366
- SEC-reported price per share
- $0.36
- Number of holders
- 24
- Value change
- +$584,687
- Number of buys
- 10
- Number of sells
- 8
- Shares outstanding
- 1,651,503
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
24
Top holders
10
AEMD full security history
Ownership snapshot
Full 13F holder table
AETHLON MEDICAL INC SEC filings
AETHLON MEDICAL INC company facts
Broader feeds
Ownership snapshot
Top reported holders of AEMD - Aethlon Medical, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Ikarian Capital, LLC
Disclosed value leader
Ikarian Capital, LLC
Comparable rows
0/15
Latest evidence
31 Dec 2024
13F
3/4/5
Highest disclosed value: $645,001
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Ikarian Capital, LLC has the largest disclosed position value at $645K.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Ikarian Capital, LLC's linked filing trail.
Disclosed position value
Top 5
Ikarian Capital, LLC
$645K
UBS Group AG
$214.6K
BOOTHBAY FUND MANAGEMENT, LLC
$186.3K
GEODE CAPITAL MANAGEMENT, LLC
$94.9K
Virtu Financial LLC
$81K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Ikarian Capital, LLC |
13F
Company
|
—
denominator unverified
|
$645,001
750,000 shares
|
— | 31 Dec 2024 |
| UBS Group AG |
13F
Company
|
—
denominator unverified
|
$214,599
249,535 shares
|
— | 31 Dec 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$186,276
216,600 shares
|
— | 31 Dec 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$94,886
110,333 shares
|
— | 31 Dec 2024 |
| Virtu Financial LLC |
13F
Company
|
—
denominator unverified
|
$81,000
94,173 shares
|
— | 31 Dec 2024 |
| Sabrina Martucci Johnson |
3/4/5
Director
|
—
denominator unverified
|
$73,676
33,642 shares
|
— | 31 Mar 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
24
Shares
3,383,404
Rows available
24
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2025 Across Filers
Q1 2025 holders
24
Q1 2025 holders
24
Holder diff
0
| Investor | Q1 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|